# Remaxol® in Mechanical Jaundice of Non-malignant Origin

> **NCT03418935** · PHASE3 · COMPLETED · sponsor: **POLYSAN Scientific & Technological Pharmaceutical Company** · enrollment: 342 (actual)

## Conditions studied

- Jaundice, Obstructive

## Interventions

- **DRUG:** Remaxol (succinate + methionine + inosine + nicotinamide)
- **DRUG:** Ringer's Solution

## Key facts

- **NCT ID:** NCT03418935
- **Lead sponsor:** POLYSAN Scientific & Technological Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-03
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-04-13
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03418935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03418935, "Remaxol® in Mechanical Jaundice of Non-malignant Origin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03418935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*